Alpha DNA Investment Management’s Palantir PLTR Stock Holding History

Alpha DNA Investment Management’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,413	Closed	-$863K	–	130
2024 Q4	$863K	Buy	+11,413	New	+$665K	0.33%	62
2021 Q2	–	Sell	-153	Closed	-$3K	–	497
2021 Q1	$3K	Buy	+153	New	+$4.2K	﹤0.01%	501

Other funds holding PLTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alpha DNA Investment Management's PLTR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Palantir (PLTR) in Q1 2025, closing a stake of 11,413 shares — an estimated $863K sold.

Alpha DNA Investment Management first reported a position in PLTR in Q1 2021 and held it in 2 quarters. The position peaked at $863K in Q4 2024. 2,190 funds tracked by Wall St. Rank hold PLTR as of Q1 2025.

Alpha DNA Investment Management reported no remaining Palantir position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 11,413 Palantir shares in Q1 2025, an estimated $863K.
Alpha DNA Investment Management first reported a position in Palantir in Q1 2021 and held it in 2 quarters.
Alpha DNA Investment Management's Palantir position peaked at $863K in Q4 2024.
2,190 funds tracked by Wall St. Rank held Palantir as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.